Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iSPECTcardiac is a medical technology company specializing in the development of advanced nuclear imaging solutions for cardiology. The company's primary product is a dedicated cardiac SPECT (Single Photon Emission Computed Tomography) system designed to provide high-resolution imaging of the heart with improved sensitivity and reduced scan times compared to traditional general-purpose systems. By utilizing a unique detector geometry and advanced reconstruction algorithms, iSPECTcardiac aims to enhance the diagnosis and management of coronary artery disease and other cardiovascular conditions. The technology is positioned to offer a more cost-effective and patient-friendly alternative for hospitals and outpatient clinics. The system's compact design allows for easier integration into existing clinical workflows while maintaining superior diagnostic performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iSPECTcardiac.